Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia.

Chen J, Abella Ross J, Tegtmeier B, Yang D, Ito JI, Zaia JA, Dickter JK, Nakamura R, Mokhtari S, Kriengkauykiat J, Al Malki MM, Dadwal SS.

Transpl Infect Dis. 2019 Dec 15:e13233. doi: 10.1111/tid.13233. [Epub ahead of print]

PMID:
31840347
2.

Modulation of the coordination geometries of NCN and NCNC Rh complexes for ambidextrous chiral catalysts.

Ito JI, Ishihara T, Fukuoka T, Binti Mat Napi SR, Kameo H, Nishiyama H.

Chem Commun (Camb). 2019 Nov 4;55(85):12765-12768. doi: 10.1039/c9cc06520b. Epub 2019 Sep 26.

PMID:
31556411
3.

Does improvement of cognitive functioning by cognitive remediation therapy effect work outcomes in severe mental illness? A secondary analysis of a randomized controlled trial.

Ikebuchi E, Sato S, Yamaguchi S, Shimodaira M, Taneda A, Hatsuse N, Watanabe Y, Sakata M, Satake N, Nishio M, Ito JI.

Psychiatry Clin Neurosci. 2017 May;71(5):301-308. doi: 10.1111/pcn.12486. Epub 2017 Jan 10.

4.

Co6 H8 (Pi Pr3 )6 : A Cobalt Octahedron with Face-Capping Hydrides.

Ohki Y, Shimizu Y, Araake R, Tada M, Sameera WM, Ito JI, Nishiyama H.

Angew Chem Int Ed Engl. 2016 Dec 19;55(51):15821-15825. doi: 10.1002/anie.201608262. Epub 2016 Nov 16.

PMID:
27862749
5.

Enantioselective Direct Alkynylation of Ketones Catalyzed by Chiral CCN Pincer RhIII Complexes.

Ito JI, Ubukata S, Muraoka S, Nishiyama H.

Chemistry. 2016 Nov 14;22(47):16801-16804. doi: 10.1002/chem.201603754. Epub 2016 Oct 13.

PMID:
27605170
6.

Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C.

J Natl Compr Canc Netw. 2016 Jul;14(7):882-913.

PMID:
27407129
7.

Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.

Champer J, Ito JI, Clemons KV, Stevens DA, Kalkum M.

J Fungi (Basel). 2016 Mar;2(1). pii: 6. Epub 2016 Jan 12.

8.

Biochemical properties in membrane of rat astrocytes under oxidative stress.

Ito JI, Nagayasu Y, Ogawa T, Okihara H, Michikawa M.

Brain Res. 2015 Jul 30;1615:1-11. doi: 10.1016/j.brainres.2015.04.008. Epub 2015 Apr 13.

PMID:
25881893
9.

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Kauffman CA, Freifeld AG, Andes DR, Baddley JW, Herwaldt L, Walker RC, Alexander BD, Anaissie EJ, Benedict K, Ito JI, Knapp KM, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Schuster MG, Chiller TM, Pappas PG.

Transpl Infect Dis. 2014 Apr;16(2):213-24. doi: 10.1111/tid.12186. Epub 2014 Mar 4.

10.

Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review.

Davies-Vorbrodt S, Ito JI, Tegtmeier BR, Dadwal SS, Kriengkauykiat J.

Pharmacotherapy. 2013 Jan;33(1):22-30. doi: 10.1002/phar.1156. Review.

PMID:
23307541
11.

Enhancing angiogenesis in invasive aspergillosis: a novel therapeutic approach.

Ito JI.

J Infect Dis. 2013 Apr;207(7):1031-3. doi: 10.1093/infdis/jis944. Epub 2013 Jan 9. No abstract available.

PMID:
23303815
12.

Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens.

Champer J, Diaz-Arevalo D, Champer M, Hong TB, Wong M, Shannahoff M, Ito JI, Clemons KV, Stevens DA, Kalkum M.

Ann N Y Acad Sci. 2012 Dec;1273:44-51. doi: 10.1111/j.1749-6632.2012.06761.x.

PMID:
23230836
13.

Prevention and treatment of cancer-related infections.

Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1412-45.

PMID:
23138169
14.

Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine.

Diaz-Arevalo D, Ito JI, Kalkum M.

Front Microbiol. 2012 Aug 22;3:299. eCollection 2012.

15.

Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kauffman CA, Kontoyiannis DP, Ito JI, Schuster MG, Brizendine KD, Patterson TF, Lyon GM, Boeckh M, Oster RA, Chiller T, Pappas PG.

Med Mycol. 2013 Feb;51(2):128-35. doi: 10.3109/13693786.2012.690108. Epub 2012 Jun 11.

PMID:
22680976
16.

Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.

Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt L, Ito JI, Kauffman CA, Lyon GM, Marr KA, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wingard JR, Walsh TJ, Kontoyiannis DP.

Emerg Infect Dis. 2011 Oct;17(10):1855-64. doi: 10.3201/eid1710.110087.

17.

Unveiling the roles of the glutathione redox system in vivo by analyzing genetically modified mice.

Fujii J, Ito JI, Zhang X, Kurahashi T.

J Clin Biochem Nutr. 2011 Sep;49(2):70-8. doi: 10.3164/jcbn.10-138SR. Epub 2011 Jun 3.

18.

T cell immunity and vaccines against invasive fungal diseases.

Ito JI.

Immunol Invest. 2011;40(7-8):825-38. doi: 10.3109/08820139.2011.595472. Epub 2011 Aug 4. Review.

PMID:
21815776
19.

Epidemiology and treatment approaches in management of invasive fungal infections.

Kriengkauykiat J, Ito JI, Dadwal SS.

Clin Epidemiol. 2011;3:175-91. doi: 10.2147/CLEP.S12502. Epub 2011 May 19.

20.

In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Lockhart SR, Zimbeck AJ, Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Pappas PG, Chiller T.

Antimicrob Agents Chemother. 2011 Aug;55(8):3944-6. doi: 10.1128/AAC.00428-11. Epub 2011 Jun 13.

21.

Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006.

Lockhart SR, Wagner D, Iqbal N, Pappas PG, Andes DR, Kauffman CA, Brumble LM, Hadley S, Walker R, Ito JI, Baddley JW, Chiller T, Park BJ.

J Clin Microbiol. 2011 Jul;49(7):2404-10. doi: 10.1128/JCM.02474-10. Epub 2011 May 11.

22.

(99m)Tc-GSA SPECT analysis was clinically useful to evaluate the effect of interferon in a patient with interferon non-responsive chronic hepatitis C.

Ishii R, Togashi H, Iwaba A, Sato C, Haga H, Sanjo M, Okumoto K, Nishise Y, Ito JI, Watanabe H, Saito K, Okada A, Takahashi K, Saito T, Kawata S.

Ann Nucl Med. 2011 Aug;25(7):520-3. doi: 10.1007/s12149-011-0484-0. Epub 2011 Apr 2.

PMID:
21461597
23.

CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.

Diaz-Arevalo D, Bagramyan K, Hong TB, Ito JI, Kalkum M.

Infect Immun. 2011 Jun;79(6):2257-66. doi: 10.1128/IAI.01311-10. Epub 2011 Mar 21.

24.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.

PMID:
21258094
25.

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of Americaa.

Clin Infect Dis. 2011 Feb 15;52(4):427-31. doi: 10.1093/cid/ciq147. Epub 2011 Jan 4.

PMID:
21205990
26.

Approaches to the early treatment of invasive fungal infection.

Ito JI, Kriengkauykiat J, Dadwal SS, Arfons LM, Lazarus HM.

Leuk Lymphoma. 2010 Sep;51(9):1623-31. doi: 10.3109/10428194.2010.496504. Review.

PMID:
20629521
27.

Factors associated with mortality in transplant patients with invasive aspergillosis.

Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, Oster RA, Anaissie EJ, Walsh TJ, Schuster MG, Wingard JR, Patterson TF, Ito JI, Williams OD, Chiller T, Pappas PG.

Clin Infect Dis. 2010 Jun 15;50(12):1559-67. doi: 10.1086/652768.

28.

Relationship between alcohol consumption and serum adiponectin levels: the Takahata study--a cross-sectional study of a healthy Japanese population.

Nishise Y, Saito T, Makino N, Okumoto K, Ito JI, Watanabe H, Saito K, Togashi H, Ikeda C, Kubota I, Daimon M, Kato T, Fukao A, Kawata S.

J Clin Endocrinol Metab. 2010 Aug;95(8):3828-35. doi: 10.1210/jc.2009-1862. Epub 2010 May 5.

PMID:
20444927
29.

TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection.

Ouburg S, Lyons JM, Land JA, den Hartog JE, Fennema JS, de Vries HJ, Bruggeman CA, Ito JI, Peña AS, Lundberg PS, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:83-93.

PMID:
20011699
30.

TLR4 in Chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility.

den Hartog JE, Lyons JM, Ouburg S, Fennema JS, de Vries HJ, Bruggeman CA, Ito JI, Peña AS, Land JA, Morré SA.

Drugs Today (Barc). 2009 Nov;45 Suppl B:75-82.

PMID:
20011698
31.

Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.

Baddley JW, Marr KA, Andes DR, Walsh TJ, Kauffman CA, Kontoyiannis DP, Ito JI, Balajee SA, Pappas PG, Moser SA.

J Clin Microbiol. 2009 Oct;47(10):3271-5. doi: 10.1128/JCM.00854-09. Epub 2009 Aug 19.

32.

Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.

Michallet M, Ito JI.

J Clin Oncol. 2009 Jul 10;27(20):3398-409. doi: 10.1200/JCO.2008.20.1178. Epub 2009 Jun 1. Review.

PMID:
19487382
33.

Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population.

Saito T, Nishise Y, Makino N, Haga H, Ishii R, Okumoto K, Ito JI, Watanabe H, Saito K, Takeda H, Togashi H, Kubota I, Daimon M, Kato T, Kawata S.

Metabolism. 2009 Aug;58(8):1067-75. doi: 10.1016/j.metabol.2009.03.008. Epub 2009 Jun 18.

PMID:
19411086
34.

Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.

Yokozawa J, Sasaki T, Ohwada K, Sasaki Y, Ito JI, Saito T, Kawata S.

J Gastroenterol. 2009;44(6):583-91. doi: 10.1007/s00535-009-0042-x. Epub 2009 Apr 14.

PMID:
19365601
35.

Vaccine progress.

Ito JI, Lyons JM, Diaz-Arevalo D, Hong TB, Kalkum M.

Med Mycol. 2009;47 Suppl 1:S394-400. doi: 10.1080/13693780802552614. Epub 2009 Feb 26. Review.

PMID:
19247869
36.

Prevention and treatment of cancer-related infections.

Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS.

J Natl Compr Canc Netw. 2008 Feb;6(2):122-74. Review. No abstract available.

PMID:
18319048
37.

Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.

Nishise Y, Saito T, Sugahara K, Ito JI, Saito K, Togashi H, Nagano-Fujii M, Hotta H, Kawata S.

J Infect Dis. 2007 Oct 1;196(7):1006-9. Epub 2007 Aug 23.

PMID:
17763321
38.

Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis.

Okumoto K, Saito T, Onodera M, Sakamoto A, Tanaka M, Hattori E, Haga H, Ito JI, Sugahara K, Saito K, Togashi H, Kawata S.

J Gastroenterol Hepatol. 2007 Aug;22(8):1265-70.

PMID:
17688667
39.
40.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
41.

Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis.

Ito JI, Lyons JM, Hong TB, Tamae D, Liu YK, Wilczynski SP, Kalkum M.

Infect Immun. 2006 Sep;74(9):5075-84.

42.
43.

Description of the ICTI consortium: an integrated approach to the study of Chlamydia trachomatis infection.

Morré SA, Spaargaren J, Ossewaarde JM, Land JA, Bax CJ, Dörr PJ, Oostvogel PM, Vanrompay D, Savelkoul PH, Pannekoek Y, van Bergen JE, Fennema HS, de Vries HJ, Crusius JB, Peña AS, Ito JI, Lyons JM.

Drugs Today (Barc). 2006 Mar;42 Suppl A:107-14. Review.

PMID:
16683050
44.

Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver.

Okumoto K, Saito T, Haga H, Hattori E, Ishii R, Karasawa T, Suzuki A, Misawa K, Sanjo M, Ito JI, Sugahara K, Saito K, Togashi H, Kawata S.

J Gastroenterol. 2006 Jan;41(1):62-9.

PMID:
16501859
45.

Antibacterial prophylaxis in patients with cancer and neutropenia.

Ito JI, Tegtmeier BR, O'Donnell MR.

N Engl J Med. 2006 Jan 5;354(1):90-4; author reply 90-4. No abstract available.

PMID:
16395829
46.

Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.

Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI.

J Microbiol Immunol Infect. 2005 Dec;38(6):383-93.

PMID:
16341338
47.
48.
49.

Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C.

Watanabe H, Saito T, Karasawa T, Kudo S, Nakano K, Ito JI, Sugahara K, Saito K, Togashi H, Kawata S.

Hepatol Res. 2005 Sep;33(1):14-8. Epub 2005 Aug 19.

PMID:
16112898
50.

The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D infection in a murine model.

Lyons JM, Ito JI Jr, Morré SA.

Infect Dis Obstet Gynecol. 2005 Mar;13(1):1-3. No abstract available.

Supplemental Content

Support Center